Table 1.
Diagnostic Yield of New Screening Test T Compared with Standard Test S for Colorectal Cancer (CRC), 100,000 Subjects.
Disease | Test Positives | Test Negatives | ||||
---|---|---|---|---|---|---|
Status | S+ | T+ | Δ+ | S− | T− | Δ − |
Absent | 4965 | 14895 | 9930 | 94335 | 84405 | −9930 |
Presenta | 525 | 630 | 105 | 175 | 70 | −105 |
| ||||||
Ratio | 9.5 | 23.6 | 94.6 | 539.1 | 1205.8 | 94.6 |
FP AEsb | 33.8 | 101.3 | 67.5 | |||
ΔFP AEs/ΔTP | 0.64 | |||||
|
Prevalence of disease (CRC) is assumed to be 0.7%, or 700 per 100,000 subjects.
Risk of an adverse event during colonoscopy is assumed to be 0.68% (Rutter et al, 2012, Table 2). All subjects falsely testing positive are assumed to be referred to colonoscopy and undergo the procedure.